Abbott edges out Boston Scientific in the MedTech faceoff, with valuation appeal, strong CGM momentum and strategic deals boosting its investment case.

New York, New York--(Newsfile Corp. - February 19, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation ("Boston Scientific Corporation") (NYSE: BSX) concerning potential violations of the federal securities laws. On February 4, 2026, Boston Scientific reported fourth-quarter 2025 results.

NEW YORK, Feb. 19, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE: BSX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com  or 646-581-9980, ext.

Sometimes the best new ideas are simply old winners ready for another run.

Boston Scientific Corporation (NYSE: BSX - Get Free Report) has been given a consensus rating of "Moderate Buy" by the twenty-four analysts that are covering the stock, Marketbeat.com reports. Three research analysts have rated the stock with a hold recommendation, twenty have given a buy recommendation and one has issued a strong buy recommendation on the

Insightful Analysis of Lee Ainslie (Trades, Portfolio)'s Fourth Quarter 2025 13F Filing Lee Ainslie (Trades, Portfolio) recently submitted the 13F filing for t

Atria Investments Inc boosted its position in shares of Boston Scientific Corporation (NYSE: BSX) by 85.8% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 77,476 shares of the medical equipment provider's stock after purchasing an additional 35,788 shares during the period.

Insights from Frank Sands (Trades, Portfolio)' Fourth Quarter 2025 13F Filing Frank Sands (Trades, Portfolio) recently submitted the 13F filing for the fourth

Boston Scientific  BSX reported its fourth-quarter 2025 results on Feb. 4. Both top and bottom lines exceeded the company's guidance ranges and topped the respective Zacks Consensus Estimate.

MARLBOROUGH, Mass., Feb. 13, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in TD Cowen's 46th Annual Health Care Conference on Tuesday, March 3, 2026.